Shao Miriam M, White Timothy G, Bassett Jared B, Dowlati Ehsan, Mehta Shyle H, Werner Cassidy, Golub Danielle, Shah Kevin A, Dehdashti Amir R, Teron Ina, Link Thomas, Patsalides Athos, Woo Henry H
Department of Neurosurgery, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, North Shore University Hospital, Manhasset, NY 11030, USA.
J Clin Med. 2024 Oct 16;13(20):6162. doi: 10.3390/jcm13206162.
: The endovascular treatment of complex intracranial aneurysms, such as wide-neck aneurysms (WNAs), remains a challenge. More established endovascular techniques, which include balloon-assisted coiling, stent-assisted coiling, and flow diversion, all have their drawbacks. Intrasaccular flow disruptor devices have emerged as a useful tool for the neurointerventionalist. : Here, we discuss landmark studies and provide a comprehensive, narrative review of the Woven EndoBridge (WEB; Microvention, Alisa Viejo, CA, USA), Artisse (Medtronic, Irvine, CA, USA), Contour (Stryker, Kalamazoo, MI, USA), Saccular Endovascular Aneurysm Lattice Embolization System (SEAL; Galaxy Therapeutics Inc, Milpitas, CA, USA), Medina (Medtronic, Irvine, CA, USA), and Trenza (Stryker, Kalamazoo, MI, USA) devices. : Intrasaccular devices have proven to be effective in treating complex aneurysms like WNAs. : Intrasaccular flow disruptors have emerged as a new class of effective endovascular therapy, and results of ongoing clinical studies for the newer devices (e.g., SEAL and Trenza) are much anticipated.
复杂颅内动脉瘤的血管内治疗，如宽颈动脉瘤（WNA），仍然是一项挑战。更成熟的血管内技术，包括球囊辅助弹簧圈栓塞术、支架辅助弹簧圈栓塞术和血流导向术，都有其缺点。瘤内血流干扰装置已成为神经介入医生的一种有用工具。在此，我们讨论具有里程碑意义的研究，并对编织型血管内桥接器（WEB；美国加利福尼亚州阿利索维耶霍市Microvention公司）、Artisse（美国加利福尼亚州尔湾市美敦力公司）、Contour（美国密歇根州卡拉马祖市史赛克公司）、囊状血管内动脉瘤格子栓塞系统（SEAL；美国加利福尼亚州米尔皮塔斯市Galaxy Therapeutics公司）、Medina（美国加利福尼亚州尔湾市美敦力公司）和Trenza（美国密歇根州卡拉马祖市史赛克公司）装置进行全面的叙述性综述。瘤内装置已被证明在治疗如宽颈动脉瘤这样的复杂动脉瘤方面是有效的。瘤内血流干扰装置已成为一类新的有效的血管内治疗方法，人们对新型装置（如SEAL和Trenza）正在进行的临床研究结果寄予厚望。
